Systematic reviews of clinical trials indicate that in children and adolescents the efficacy of antidepressants is doubtful or invalid, which increases the risk of ideation and attempted suicide, as well as other neuropsychiatric disorders. However, these drugs are still prescribed to children and young people. The only authorized antidepressants in children and adolescents are fluoxetine (for depression), sertraline (for obsessive-compulsive disorder), and imipramine, nortriptyline and clomipramine (for nocturnal enuresis)
Teens; Depression; Pharmacological treatment
Riscos associats a l'ús d'antidepressius en joves. Barcelona: Servei Català de la Salut; 2017.
Use this identifier for quote and/or link this documenthttp://hdl.handle.net/11351/3340
This item appears in following collections
The following license files are associated with this item: